Experimental and theoretical approaches to enhance anti tubercular activity of chalcones

WSEAS Transactions on Biology and Biomedicine

Volumn 7, Issue 2, 2010, Pages 51-61

  Sivakumar, P M ^a   Kumar, Vanaja ^b   Seenivasan, S Prabhu ^b   Mohanapriya, J ^a   Doble, Mukesh ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^b NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

Anti infective; Antimycobacterial activity; Chalcones; Hydrophilic groups; Qsar; Refractivity

Indexed keywords

4 METHYLSULFONYLCHALCONE DERIVATIVE; CHALCONE DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ACIDITY; ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROPHILICITY; MOLECULAR WEIGHT; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

MYCOBACTERIUM TUBERCULOSIS;

EID: 77951189311     PISSN: 11099518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. E. Bogatcheva, C. Hanrahan, B. Nikonenko, R. Samala, P. Chen, J. Gearhart, F. Barbosa, L. Einck, C.A. Nacy, M. Protopopova, Identification of New Diamine Scaffolds with Activity against Mycobacterium tuberculosis, Journal of Medicinal Chemistry, Vol.49, No.11, 2006, pp. 3045-3048.
2. Y.L. Janin, Antituberculosis drugs: Ten years of research, Bioorganic and Medicinal Chemistry, Vol.15, No.7, 2007, pp. 2479-2513.
3. C.B. Inderlied, C.A. Kemper, and L.E. Bermudez, The Mycobacterium avium complex, Clinical Microbiology Reviews, Vol.6, No.3, 1993, pp. 266-310.
4. G.L. Mandell, W.A.J. Petri, Goodman and Gilman's The Pharmacological Basis of Therapeutics, McGraw Hill, New York, 1996.
5. P. Sensi and G. Grassi, Burger's Medicinal Chemistry and Drug Discovery, John Wiley & Sons. Inc, New York, 1996.
6. M. Frosco and J.F. Barrett, Importance of antifungaldrug-resistance:clinical significance and need for novel therapy, Expert Opinion on Investigational Drugs, Vol.7, No.2, 1998, pp. 175-198.
7. R.C. Moellering, J.R. Graybill, J.E. McGowan, Jr, and L. Corey, Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance, American Journal of Infection Control, Vol.35, No.9, 2007, pp. S1-23.
8. Y.M. Lin, Y. Zhou, M.T. Flavin, L.M. Zhou, W. Nie, F.C. Chen, Chalcones and flavonoids as anti-Tuberculosis agents, Bioorganic and Medicinal Chemistry, Vol.10, No.8, 2002, pp. 2795-2802.
9. Z. Nowakowska, E. Wyrzykiewicz, B. Kedzia, Synthesis and antimicrobial properties of N- substituted derivatives of(E)-4- azachalcones, Farmaco, Vol.56, No.4, 2001, pp. 325-329.
10. H. Isomoto, H. Furusu, K. Ohnita, C.Y. Wen, K. Inoue, S. Kohno, Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin, World Journal of Gastroenterology, Vol.11, No.11, 2005, pp. 1629-1633.
11. V. Tomar, G. Bhattacharjee, Kamaluddin and A. Kumar, Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5- dichlorothiophene moiety, Bioorganic and Medicinal Chemistry Letters, Vol.17, No.19, 2007, pp. 5321-5324.
12. J. Lin, D.E. Rivett, and J.F.K. Wilshire, The preparation and photochemical properties of some 1,3-Diphenyl-2-pyrazolines containing a heteroaromatic substituent, Australian Journal of Chemistry, Vol.30, No.3, 1977, pp. 629-637.
13. F.A. Davis and P. Zhou, Asymmetric synthesis of the antibiotic (+)-thiamphenicol using cis- N-(p-toluenesulfinyl)aziridine2-carboxylic acids, Tetrahedron Letters, Vol.35, No.41, 1994, pp. 7525-7528.
14. P.F. Riska, Y. Su, S. Bardarov, L. Freundlich, G. Sarkis, G. Hatfull, G. Carriere, Vanaja Kumar, J. Chan, W.R. Jacobs, Jr, Rapid Film- Based Determination of Antibiotic Susceptibilities of Mycobacterium tuberculosis Strains by Using a Luciferase Reporter Phage and the Bronx Box, Journal of Clinical Microbiology, Vol.37, No.4, 1999, pp. 1144-1149.
15. L. H. Jensen, H. Liang, R. Shoemaker, M. Grauslund, M. Sehested, and B. B. Hasinoff, A Three-Dimensional Quantitative Structure- Activity Relationship Study of the Inhibition of the ATPase Activity and the Strand Passing Catalytic Activity of Topoisomerase II by Substituted Purine Analogs, Molecular Pharmacology, Vol.70, No.5, 2006, pp. 1503-1513.
16. S. Ajmani, K. Jadhav, S. A. Kulkarni, Three- Dimensional QSAR Using the k-Nearest Neighbor Method and Its Interpretation. Journal of Chemical Information and Modelling, Vol.46, No.1, 2006, pp. 24-31.
17. J.D. Fegade, R.Y. Rane, V.R. Adhari. Patil, 3D-QSAR study of benzylidene derivatives as selective Cyclooxygenase-2-inhibitors. Digest Journal of Nanomaterials and Biostructures, Vol.4, No.1, 2009, pp. 145- 154.
18. N. Stiefl, K. Baumann, Mapping Property Distributions of Molecular Surfaces: Algorithm and Evaluation of a Novel 3D Quantitative Structure-Activity Relationship Technique, Journal of Medicinal Chemistry, Vol.46, No.8, 2003, pp. 1390-1407.
19. Y.D. Aher, A. Agrawal, P.V. Bharatam, P. Garg, 3D-QSAR studies of substituted 1-(3, 3- diphenylpropyl)-piperidinyl amides and ureas as CCR5 receptor antagonists, Journal of Molecular Modeling, Vol.13, No.4, 2007, pp. 519-529.
20. A.N. Pae, S.Y. Kim, H.Y. Kim, H.J. Joo, Y. S. Cho, K.I. Choi, J.H. Choi, H.Y. Koh, QSAR studies on new oxazolidinone antibacterial agents by comparative molecular field analysis Letters, Bioorganic and Medicinal Chemistry Letters, Vol.9, No.18, 1999, pp. 2685-2690.
21. V. Raparti, T. Chitre, K. Bothara, Vanaja Kumar, S. Dangrea, C. Khachanea, S. Gorea, B. Deshmanea, Novel 4-(morpholin-4-yl)-N′- (arylidene) benzohydrazides:Synthesis, antimycobacterial activity and qsar investigations, European journal of medicinal chemistry, Vol.44, No.10, 2009, pp. 3954-3960.
22. Y. Song, Z. Shao, T.S. Dexheimer, E.S. Scher, Y. Pommier, and M. Cushman, Structure- Based Design, Synthesis, and Biological Studies of New Anti cancer Norindenoisoquinoline Topoisomerase I Inhibitors, Journal of Medicinal Chemistry, Vol.53, No.5, 2010, pp.1979-1989
23. S. Ekins, J. Rose, In silico ADME/Tox: the state of the art, Journal of Molecular Graphics and Modelling; Vol.20, No.4, 2002, pp. 305-309.
24. H. Yu, A. Adedayo, ADME-Tox in drug discovery: Integration of experimental and computational Technologies, DDT, Vol.8, No.18, 2003, pp. 852-861.
25. P. Ertl, P. Selzer, J. Muhlbacher, Web-based cheminformatics tools deployed via corporate Intranets, Ddt: Biosilico, Vol.2, No.5, 2004, pp. 201-207.
26. J. Jaganatharaja and R. Gowthaman, Computational screening of inhibitors for HIV-1 integrase using a receptor based pharmacophore model, Bioinformation, Vol.1, No.4, 2006, pp. 112-117.
27. S. G. Kucukguzel, I. Kucukguzel, E. Tatar, S. Rollas, F. Sahin, M. Gulluce, E. D. Clercq, L. Kabasakal, Synthesis of some novel heterocyclic compounds derived from diflunisal hydrazide as potential anti-infective and anti-inflammatory agents, European Journal of Medicinal Chemistry, Vol.42, No.7, 2007, pp. 893-901.
28. J.C. Aponte, M.V. Stegui, E. Malaga, M. Zimic, M. Quiliano, A.J. Vaisberg, Synthesis, Cytotoxicity, and Anti-Trypanosoma cruzi Activity of New Chalcones, Journal of Medicinal Chemistry, Vol.51, No.19, 2008, pp. 6230-6234
29. J. J. Irwin and B. K. Shoichet, ZINC - A Free Database of Commercially Available Compounds for Virtual Screening, Journal of Chemical Information and Modeling, Vol.45, No.1, 2005, pp. 177-182.
30. S. Ekins, B. Boulanger, P. W. Swaan and M. A.Z. Hupcey, Towards a new age of virtual ADME/TOX and multidimensional drug discovery, Journal of Computer-Aided Molecular Design, Vol.16, No.5-6, 2002, pp. 381-401.
31. C.H.T.P. Silva, V. B. Silva, J. Resende, P. F. Rodrigues, F.C. Bononi, C.G. Benevenuto and C.A. Taft, Computer-aided drug design and ADMET predictions for identification and evaluation of novel potential farnesyltransferase inhibitors in cancer therapy, Journal of Molecular Graphics and Modelling Vol.28, No.6, 2010, pp. 513-523.
32. L Carlsen, B. N. Kenessov, S.Y. Batyrbekova, A QSAR/QSTR study on the human health impact of the rocket fuel 1,1-dimethyl hydrazine and its transformation products. Multicriteria hazard ranking based on partial ordermethodologies, Environmental Toxicology and Pharmacology, Vol.27, No.3, 2009, 415-423.
33. P. Paixao, L. F. Gouveia, J.A.G. Morais, Prediction of drug distribution within blood, European Journal Of Pharmaceutical Sciences, Vol.36, No.4-5, 2009, pp. 544-554.
34. A. C. Lee and G. M. Crippen, Predicting pKa, Journal of Chemical Information and Modeling, Vol.49, No.9, 2009, pp. 2013-2033